Public Employees Retirement Association of Colorado reduced its position in Becton Dickinson and Co. (NYSE:BDX) by 0.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 154,565 shares of the company’s stock after selling 1,115 shares during the period. Public Employees Retirement Association of Colorado owned about 0.07% of Becton Dickinson and worth $26,213,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Virginia Retirement System bought a new stake in Becton Dickinson and during the first quarter worth approximately $519,000. Columbia Partners L L C Investment Management boosted its stake in Becton Dickinson and by 6.5% in the first quarter. Columbia Partners L L C Investment Management now owns 12,278 shares of the company’s stock worth $1,864,000 after buying an additional 744 shares during the period. Nikko Asset Management Americas Inc. bought a new stake in Becton Dickinson and during the first quarter worth approximately $168,000. NN Investment Partners Holdings N.V. bought a new stake in Becton Dickinson and during the first quarter worth approximately $1,208,000. Finally, Royal Bank of Scotland Group PLC bought a new stake in Becton Dickinson and during the first quarter worth approximately $1,215,000. 81.96% of the stock is currently owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for Becton Dickinson and (NYSE:BDX)

Shares of Becton Dickinson and Co. (NYSE:BDX) traded down 3.23% during midday trading on Tuesday, reaching $173.41. 516,774 shares of the company traded hands. The stock has a market capitalization of $36.92 billion, a P/E ratio of 33.09 and a beta of 0.93. Becton Dickinson and Co. has a 1-year low of $129.50 and a 1-year high of $181.76. The stock’s 50-day moving average is $176.53 and its 200-day moving average is $169.40.

Becton Dickinson and (NYSE:BDX) last announced its quarterly earnings results on Thursday, August 4th. The company reported $2.35 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.21 by $0.14. The company had revenue of $3.20 billion for the quarter, compared to analyst estimates of $3.21 billion. Becton Dickinson and had a net margin of 9.24% and a return on equity of 24.26%. The firm’s revenue was up 2.5% on a year-over-year basis. During the same period in the prior year, the firm posted $2.05 earnings per share. Equities analysts predict that Becton Dickinson and Co. will post $8.56 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Friday, September 30th. Stockholders of record on Friday, September 9th were given a dividend of $0.66 per share. The ex-dividend date of this dividend was Wednesday, September 7th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 1.47%. Becton Dickinson and’s dividend payout ratio (DPR) is presently 50.19%.

A number of research firms recently commented on BDX. Citigroup Inc. cut shares of Becton Dickinson and from a “neutral” rating to a “sell” rating and lowered their target price for the stock from $167.00 to $165.00 in a research note on Friday, September 23rd. Bank of America Corp. reiterated a “buy” rating on shares of Becton Dickinson and in a research note on Tuesday, July 12th. Zacks Investment Research cut shares of Becton Dickinson and from a “buy” rating to a “hold” rating in a research note on Wednesday, July 13th. Jefferies Group lifted their target price on shares of Becton Dickinson and from $190.00 to $192.00 and gave the stock a “buy” rating in a research note on Thursday, July 28th. Finally, Cowen and Company reiterated an “outperform” rating and issued a $185.00 target price on shares of Becton Dickinson and in a research note on Tuesday, August 16th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $170.82.

In other news, insider Linda M. Tharby sold 11,704 shares of the firm’s stock in a transaction that occurred on Tuesday, September 6th. The shares were sold at an average price of $177.27, for a total transaction of $2,074,768.08. Following the transaction, the insider now directly owns 22,146 shares in the company, valued at $3,925,821.42. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Gary M. Cohen sold 29,367 shares of the firm’s stock in a transaction that occurred on Thursday, August 11th. The stock was sold at an average price of $176.81, for a total transaction of $5,192,379.27. Following the transaction, the insider now owns 125,870 shares in the company, valued at $22,255,074.70. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

Becton Dickinson and Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

5 Day Chart for NYSE:BDX

Receive News & Stock Ratings for Becton Dickinson and Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Co. and related stocks with our FREE daily email newsletter.